Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734194) titled 'Remimazolam-Fentanyl Mild Conscious Sedation Regimen in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation' on July 24.

Study Type: Observational

Primary Sponsor: Charles University, Czech Republic

Condition: Atrial Fibrillation (AF)

Recruitment Status: Recruiting

Date of First Enrollment: January 1, 2026

Target Sample Size: 20

Countries of Recruitment: Czechia

To know more, visit https://clinicaltrials.gov/study/NCT07734194

Disclaimer: Curated by HT Syndication....